Broadening the spectrum of diseases related to podocin mutations. - Wikidata - wikimedia - TriplyDB

Broadening the spectrum of diseases related to podocin mutations.

Broadening the spectrum of diseases related to podocin mutations.

http://www.wikidata.org/entity/Q34192029

about

Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice The transcriptional regulation of podocin (NPHS2) by Lmx1b and a promoter single nucleotide polymorphism Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome.NPHS2 variation in focal and segmental glomerulosclerosis.Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design NPHS2 variation in sporadic focal segmental glomerulosclerosis Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations.Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms.NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: a HuGE review.Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.A novel TRPC6 mutation in a family with podocytopathy and clinical variability.Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial.Rituximab in children with resistant idiopathic nephrotic syndrome.Diabetic nephropathy: the proteinuria hypothesis.New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis.Early glomerular filtration defect and severe renal disease in podocin-deficient mice Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome.The association of podocin R229Q polymorphism with increased albuminuria or reduced estimated GFR in a large population-based sample of US adults.Molecular pathology of nephrotic syndrome in childhood: a contemporary approach to diagnosis.Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations.Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes.Educational paper: the podocytopathies.Genetics of steroid-resistant nephrotic syndrome: a review of mutation spectrum and suggested approach for genetic testing.NPHS2 mutations in steroid-resistant nephrotic syndrome: a mutation update and the associated phenotypic spectrum.Genetic testing for nephrotic syndrome and FSGS in the era of next-generation sequencing.Molecular and genetic basis of inherited nephrotic syndrome NPHS2 mutation analysis and primary nephrotic syndrome in southern Indians.A novel mutation in NPHS2 causing nephrotic syndrome in a Saudi Arabian family.Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations.The amino acid mutations of the podocin in proteinuria: a meta-analysis.Childhood nephrotic syndrome in tropical Africa: then and now.The p.R229Q variant of the NPHS2 (podocin) gene in focal segmental glomerulosclerosis and steroid-resistant nephrotic syndrome: a meta-analysis.Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.Histone deacetylase-2 expression and activity in children with nephrotic syndrome with different glucocorticoid response.Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances.Hereditary Podocytopathies in Adults: The Next Generation.Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.

P2860

Q26822256-CAB07848-77B6-4BD7-B706-53391364D8A0 Q28250170-9B61011F-536C-4D35-9F3F-665F3E3D46C9 Q33220376-9F944C1F-7A28-4CEA-AF1B-18FD6E444C4D Q33372592-E83B3F51-6A3B-4AFB-A1E5-7729C7C3DF68 Q33817568-51F32318-D3CE-4517-A62D-21376A8E8DB8 Q33897098-9AC2DAAB-6DE2-4D03-B1E7-5C5BEDE9F64F Q34013421-7A0BBA70-391F-4922-900D-09C2B5AC709C Q34405386-AC477803-7FF0-458E-BFEC-1A05B0F31F1D Q34409698-206DC058-D1EE-401F-B0C9-118456FA593E Q34495087-24494C9D-CDD9-4434-9959-ACFFBD8531E0 Q34639646-B081C197-BC89-4C4C-8C5E-5B947B27A9A8 Q34695450-1F937E48-2989-4771-9D63-733CA83644A9 Q34714573-2AED7564-9FEB-41C7-B96F-8F29FA2E0E7A Q35030581-68AD7DC2-FA38-4E7A-A5B0-717DC30D6D19 Q35982341-B3EAEA37-954A-450F-9D44-2621001CEEE0 Q36061335-1E82EE8C-6A73-4964-B7D9-A5179688F3C2 Q36124137-EFCEA48C-90BC-4232-8382-CEB785B356B9 Q36222666-E5C7482B-FE07-4065-B546-01C962C2C693 Q36796761-4E6CF255-C6E0-42DC-8970-AF9306B05A39 Q37002524-0A4EAD2A-834F-43DD-9319-C894B3D56056 Q37156672-E3EA4E3C-F0BD-43C5-979A-38B2A7F66E5B Q37211071-FAC90846-63D5-4C22-835B-4F1A6597D72F Q37802413-D9164959-B021-4E40-9015-1A112848EACE Q37975102-5C640DDA-FEBD-45AF-A1E9-10D96CB2D269 Q38114930-7F5B65C5-5E61-4389-89CA-8E112C996520 Q38162417-4B124637-909B-46FA-80C4-55A72561673A Q38193693-FA63A6A1-93E9-431F-8EFD-B3F0C77F2B55 Q38310654-73975472-9AC8-4158-A908-2260CECDEEF7 Q39221564-148235FF-959A-4BC9-A943-83604D9F30AD Q40329190-27EBED36-FCA6-47B5-9209-4CC62F934D06 Q40607516-016D8DC1-5695-4D47-8A83-EAFC11D0C15A Q40695800-0701E0F4-50AB-4E10-A3F8-9A6FE7F35E7B Q41930082-13B379F1-E36C-455A-8CF6-35F7E2B21CA6 Q43877559-7A1D3785-DA80-41E0-A2F4-8B24271DE859 Q46533455-B8BFA925-79EC-4B9C-B586-FC12A38E1AA9 Q46840795-589560B6-1B64-4A5E-A035-F3C62F3FD3F7 Q47446648-6C0A7701-3DEA-46AE-96F0-2D4269C51263 Q47653949-D614E38E-B206-4422-867F-93170226B5AD Q47861655-0955EC2A-4B98-440B-A318-5E0B70ECCB35 Q50436771-01BA445A-3989-492C-8566-D2D421AED153

P2860

Broadening the spectrum of diseases related to podocin mutations.

http://www.wikidata.org/entity/Q34192029

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Broadening the spectrum of diseases related to podocin mutations.

@ast

Broadening the spectrum of diseases related to podocin mutations.

@en

Broadening the spectrum of diseases related to podocin mutations.

@nl

type

label

Broadening the spectrum of diseases related to podocin mutations.

@ast

Broadening the spectrum of diseases related to podocin mutations.

@en

Broadening the spectrum of diseases related to podocin mutations.

@nl

prefLabel

Broadening the spectrum of diseases related to podocin mutations.

@ast

Broadening the spectrum of diseases related to podocin mutations.

@en

Broadening the spectrum of diseases related to podocin mutations.

@nl

P1433

Q34192029-AB9CF968-E76F-4F02-89B5-F2B99721CC53

P1476

Q34192029-AE208FFF-D8BA-4C6A-9BDB-49BF972964AC

P2093

Q34192029-10AF5438-ED1F-41B9-89F1-4D4AD1BE08B3

Q34192029-2FAEEBC4-434F-4E93-8F73-679B31353EF3

Q34192029-3D3333EA-401E-4B13-87A7-82D87E808FDA

Q34192029-64B026B4-EC2E-4009-8D6D-329C16FD0073

Q34192029-6757BF88-3D61-412A-B958-DF07FB26B6E4

Q34192029-73E366BC-B111-4670-8E87-56BEC8E7E158

Q34192029-9A0391EC-2CF8-4D34-B4A3-4D93698CBC1A

Q34192029-AE3ADCFD-0500-418D-90DC-6723358E6C7E

Q34192029-D6BA068C-196C-457C-AED5-147B163CFBCB

Q34192029-E9D4384F-612C-4B54-A9A2-8C130DF6B546

P304

Q34192029-D2B1B7D4-6C45-4082-93A8-3BDE1D9DDF2C

P31

Q34192029-44C0E696-A4D7-4D9E-BC8F-5FD6FA199FDF

P356

Q34192029-4D28E087-6C26-4F7F-8C0A-FE151D1C3C17

P433

Q34192029-ACB5B4B4-D8E3-479C-B21F-7D0DF48E0775

P478

Q34192029-A3A9C899-3577-43EB-9B04-9F7F6B583EDF

P50

Q34192029-03D55801-6831-45EA-9D5D-61001D214E52

Q34192029-438D272D-49F1-40F3-A074-E22E20E0918D

Q34192029-8192B605-CF9E-47F5-9066-D25E55CAABB6

Q34192029-F9B081E2-2C47-4FDD-AADD-B5DCCB7A7012

P577

Q34192029-79AC7281-A79F-496B-B00B-800E2BD69225

P698

Q34192029-704F12CA-D9FD-47A1-BF19-997E6FB85FAD

P356

01.ASN.0000060578.79050.E0

P1433

Journal of the American Society of Nephrology

P1476

Broadening the spectrum of diseases related to podocin mutations.

@en

P2093

Alba Carrea

http://www.w3.org/2001/XMLSchema#string

Francesco Emma

http://www.w3.org/2001/XMLSchema#string

Francesco Perfumo

http://www.w3.org/2001/XMLSchema#string

Francesco Scolari

http://www.w3.org/2001/XMLSchema#string

Gianfranco Rizzoni

http://www.w3.org/2001/XMLSchema#string

Gianna Mazzucco

http://www.w3.org/2001/XMLSchema#string

Laura Massella

http://www.w3.org/2001/XMLSchema#string

Marco Di Duca

http://www.w3.org/2001/XMLSchema#string

Monica Dagnino

http://www.w3.org/2001/XMLSchema#string

Nunzia Miglietti

http://www.w3.org/2001/XMLSchema#string

P304

1278-1286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/01.ASN.0000060578.79050.E0

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Gian Marco Ghiggeri

Gianluca Caridi

Andrea Onetti Muda

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12707396

http://www.w3.org/2001/XMLSchema#string